1Oppenheimer Federico,Aljama Pedro,Peinado Concepción Asensio,et al.The impact of donor age on the results of renal transplantation[J].Nephrology Dialysis Transplantation,2004,19(suppl):111-15.
2Fulladosa X,Moreso F,Narvaez JA,et al.Estimation of total glomerular number in stable renal transplants[J].Journal of the American Society of Nephrology,2003,14(10):2662-2668.
3Oh CK,Jeon KO,Kim HJ,et al.Metabolic demand and renal mass supply affecting the early graft function after living donor kidney transplantaion[J].Kidney International,2005,67(2):744-749.
6Choi BS,Shin MJ,Kim KS,et al.Clinical significance of an early protocol biopsy in living-donor renal transplantation:ten-year experience at a single center[J].American Journal of Transplantation,2005,5(6):1354-1360.
7Veronese FV,Noronha IL,Manfro RC,et al.Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome[J].Clinical Transplantation,2004,18(4):357-364.
8Poggio ED,Clemente M,Riley J,et al.Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy[J].J Am Soc Nephrol,2004;15:1952-1960.
9Aragao E.,Moura LA,Pacheco-Silva A.Monitoring anti-HLA Class I IgG antibodies in renal transplant recipients[J].Transplantation Proceedings,2004,36(4):836-837.
10He Xiang,Johnston.Atholl.Risk factors for allograft failure in United Kingdom renal transplant recipients treated with cyclosporine A[J].Clinical Transplantation,2005,79(8):953-957.
二级参考文献45
1Kaija I,Anu S,Leena K,et al.Cytomegalovirus increases collagen synthesis in chronic rejection in the louse.Nephrol-Dial-Transplant,2002,17(5):772-779.
2Tsalamandris C,Young KW.The tricontinental Mycophenylate Mofetil renal transplantation study group.Transplantation,1996,61(9):1029-1037.
3Celik B,Randhawa PS.Glomerular changes in BK virus nephropathy.Human Pathology,2004,35(3):367-370.
4Celik B,Randhawa PS.Glomerular changes in BK virus nephropathy.Human Pathology,2004,35(3):367-370.
5Yamurdur MC,Sevmis S,Emiro R,et al.Tacrolimus conversion in kidney transplant recipients:analysis of 107 patients.Transplantation Proceedings,2004,36(1):144-147.
6Roodnat JI, Mulder PG, Rischen-Vos J,et al. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation ,2001,72: 438
7Fernandez-Fresnedo G, Rodrigo E, Escallada R, et al. The risk of cardiovascular disease associated with proteinuria in renal transplant patients. Transplantation,2002, 73: 1345
8Borchhardt K, Haas N, Yilmaz N, et al.Low dose angiotensin converting enzyme inhibition and glomerular permselectivity in renal transplant recipients. Kidney Int, 1997, 52: 1622
9Lufft V, Kliem V, Hamkens A,et al. Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage. Clin Transplant, 1998,12 (5) :409
10Lin J, Valeri AM, Markowitz GS, et al. Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation,2002,73: 783
